Blood Gas Analyzer Market size is anticipated to reach USD 10 Billion by the end of 2036, growing at a CAGR of 5% during the forecast period i.e., 2024-2036. In the year 2023, the industry size of blood gas analyzers was over USD 2 Billion. The whole blood specimen's blood gas, pH, electrolyte, and certain metabolites are measured using blood gas analyzers. The main reasons propelling the market during this time are rapid urbanization, changing lifestyles, unhealthy eating habits, blood vessel bleeding, chronic illnesses, and technological improvements in the device. These analyzers are perfect for point-of-care testing and have several benefits for patients receiving critical care. For example, as of September 2021, 1,260,000 new and recurrent coronary attacks occur annually, according to the National Heart, Lung, and Blood Institute's Atherosclerotic Risk in Communities study and Cardiovascular Health Study; approximately 37% of individuals who experience a coronary attack in a given year pass away from it.
The global market for blood gas analyzers could see substantial growth if telemetry systems are integrated with blood gas analyzers. A growing trend in healthcare is remote patient monitoring, and using telemetry and blood gas analyzers together enables continuous patient monitoring from a distance. This can assist in resolving several enduring issues. Blood gas analyzers become much more useful when they can be integrated with telemetry; this opens up new clinical applications and paves the way for increased use of the devices in various care settings in the years to come. If companies in the blood gas analyzers market adjust to include these quickly developing connectivity capabilities, this offers them great growth prospects.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024 - 2036 |
|
CAGR |
~5% |
|
Base Year Market Size (2023) |
~USD 2 billion |
|
Forecast Year Market Size (2036) |
~USD 10 billion |
|
Regional Scope |
|
Modality (Portable, Bench-top)
Based on modality, the portable segment in the blood gas analyzer market is anticipated to hold the largest revenue share of 80% by the end of 2036. The portable gadgets have a higher adoption rate because they are simple to use, and manage, and need little upkeep. Numerous businesses are contributing to the creation and promotion of these goods. The segment is expanding due in part to an increase in product launches and partnerships. At MEDICA 2021, Boditech Med unveiled the AFIAS-10 immunoassay analyzer with a blood collection tube, which has an all-in-one cartridge system. A special integrated Sample-to-Answer system called the AFIAS-10 can run 10 tests in parallel for every parameter. Using automatic blood tube sample collection, AFIAS-10 offers a dependable test result with a fast and easy-to-use interface.
End Users (Hospitals, Diagnostics Centers, Clinical Labs, Ambulatory Surgical Centers, Educational Institutes, Others)
In terms of end-use, the clinical laboratory segment in the blood gas analyzer market is set to hold the highest CAGR by the end of the forecast period. In the forecast years, this segment of healthcare laboratories is expected to expand at a fast pace. Blood gas analyzers are typically larger, benchtop instruments that are capable of handling a higher volume of samples and performing a wider range of tests in clinical laboratories.
Our in-depth analysis of the global blood gas analyzer market includes the following segments:
|
Product Type |
|
|
Modality |
|
|
End Users |
|
North American Market Forecasts
The blood gas analyzer market in the North American region is anticipated to grow at a revenue share of 80% by the end of 2036. In this region, the opportunities for companies in blood gas analyzers are projected to be very attractive due to increasing healthcare costs and the swift uptake of new technology. The importance of this market in the United States is driven by improved networks between multidisciplinary hospitals, insurance companies, and medical device manufacturers. For example, the United States Food and Drug Administration approved the Siemens Healthineers RAPIDPoint 500e Blood Gas Analyzer, used in critical care, in March 2020.
European Market Statistics
The blood gas analyzer market is estimated to hold a significant revenue share during the projected period. In particular, due to the increasing demand from larger, medium, and smaller hospitals in Europe's main countries for automated analyzers capable of fast multiparameter testing, Europe continues to grow. More diagnostics are being performed as a result of an increase in healthcare infrastructure and availability. The need for high throughput blood gas analyzers to efficiently manage workload is driven by this requirement. Up to 120 tests an hour can be performed with high precision by the majority of today's tools.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?